We first tested the expression of the epidermal marker E-cadherin, the mesenchymal marker Vimentin, and miR-137 in three BC cell lines (MDA-MB-468, HCC1937, MCF-7) when treated with DOX at a concentration of their respective IC50. Here, VIM is linked to breast cancer.